BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 23851496)

  • 61. Regulation of T-cell survival and mitochondrial homeostasis by TSC1.
    O'Brien TF; Gorentla BK; Xie D; Srivatsan S; McLeod IX; He YW; Zhong XP
    Eur J Immunol; 2011 Nov; 41(11):3361-70. PubMed ID: 21805467
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells.
    Li J; Csibi A; Yang S; Hoffman GR; Li C; Zhang E; Yu JJ; Blenis J
    Proc Natl Acad Sci U S A; 2015 Jan; 112(1):E21-9. PubMed ID: 25524627
    [TBL] [Abstract][Full Text] [Related]  

  • 63. mTOR complex 1 activity is required to maintain the canonical endocytic recycling pathway against lysosomal delivery.
    Dauner K; Eid W; Raghupathy R; Presley JF; Zha X
    J Biol Chem; 2017 Apr; 292(14):5737-5747. PubMed ID: 28196862
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Loss of TSC2 confers resistance to ceramide and nutrient deprivation.
    Guenther GG; Liu G; Ramirez MU; McMonigle RJ; Kim SM; McCracken AN; Joo Y; Ushach I; Nguyen NL; Edinger AL
    Oncogene; 2014 Apr; 33(14):1776-87. PubMed ID: 23604129
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dengue Virus Activates the AMP Kinase-mTOR Axis To Stimulate a Proviral Lipophagy.
    Jordan TX; Randall G
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298606
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mammalian target of rapamycin complex 1 (mTORC1) enhances bortezomib-induced death in tuberous sclerosis complex (TSC)-null cells by a c-MYC-dependent induction of the unfolded protein response.
    Babcock JT; Nguyen HB; He Y; Hendricks JW; Wek RC; Quilliam LA
    J Biol Chem; 2013 May; 288(22):15687-98. PubMed ID: 23612979
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators.
    Shi K; Parekh VI; Roy S; Desai SS; Agarwal SK
    Endocr Relat Cancer; 2013 Feb; 20(1):111-22. PubMed ID: 23419452
    [TBL] [Abstract][Full Text] [Related]  

  • 68. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity.
    Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP
    Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors.
    Huang J; Wu S; Wu CL; Manning BD
    Cancer Res; 2009 Aug; 69(15):6107-14. PubMed ID: 19602587
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Establishment of Tsc2‑deficient rat embryonic stem cells.
    Ito Y; Kawano H; Kanai F; Nakamura E; Tada N; Takai S; Horie S; Arai H; Kobayashi T; Hino O
    Int J Oncol; 2015 May; 46(5):1944-52. PubMed ID: 25738543
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The cochaperone BAG3 coordinates protein synthesis and autophagy under mechanical strain through spatial regulation of mTORC1.
    Kathage B; Gehlert S; Ulbricht A; Lüdecke L; Tapia VE; Orfanos Z; Wenzel D; Bloch W; Volkmer R; Fleischmann BK; Fürst DO; Höhfeld J
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):62-75. PubMed ID: 27756573
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent.
    Parkhitko A; Myachina F; Morrison TA; Hindi KM; Auricchio N; Karbowniczek M; Wu JJ; Finkel T; Kwiatkowski DJ; Yu JJ; Henske EP
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12455-60. PubMed ID: 21746920
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice.
    Kladney RD; Cardiff RD; Kwiatkowski DJ; Chiang GG; Weber JD; Arbeit JM; Lu ZH
    Cancer Res; 2010 Nov; 70(21):8937-47. PubMed ID: 20940396
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Control of HIF-1{alpha} and vascular signaling in fetal lung involves cross talk between mTORC1 and the FGF-10/FGFR2b/Spry2 airway branching periodicity clock.
    Scott CL; Walker DJ; Cwiklinski E; Tait C; Tee AR; Land SC
    Am J Physiol Lung Cell Mol Physiol; 2010 Oct; 299(4):L455-71. PubMed ID: 20622121
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) is a negative regulator of the mammalian target of rapamycin complex 1 (mTORC1).
    Li L; Guan KL
    J Biol Chem; 2013 Jan; 288(1):703-8. PubMed ID: 23184942
    [TBL] [Abstract][Full Text] [Related]  

  • 76. REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling.
    Dennis MD; Coleman CS; Berg A; Jefferson LS; Kimball SR
    Sci Signal; 2014 Jul; 7(335):ra68. PubMed ID: 25056877
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nuclear Akt2 opposes limbal keratinocyte stem cell self-renewal by repressing a FOXO-mTORC1 signaling pathway.
    Saoncella S; Tassone B; Deklic E; Avolio F; Jon C; Tornillo G; De Luca E; Di Iorio E; Piva R; Cabodi S; Turco E; Pandolfi PP; Calautti E
    Stem Cells; 2014 Mar; 32(3):754-69. PubMed ID: 24123662
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Maternal diabetes promotes mTORC1 downstream signalling in rabbit preimplantation embryos.
    Gürke J; Schindler M; Pendzialek SM; Thieme R; Grybel KJ; Heller R; Spengler K; Fleming TP; Fischer B; Navarrete Santos A
    Reproduction; 2016 May; 151(5):465-76. PubMed ID: 26836250
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling.
    Peng M; Yin N; Li MO
    Cell; 2014 Sep; 159(1):122-133. PubMed ID: 25259925
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shift.
    Medvetz D; Priolo C; Henske EP
    Mol Cancer Res; 2015 Jan; 13(1):3-8. PubMed ID: 25298408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.